Citation: G. Olesen et al., Long-term culture of hematopoietic stem cells - validating the stromal component of the CAFC assay, CYTOTHERAPY, 3(2), 2001, pp. 107-116
Authors:
Uckun, FM
Pallisgaard, N
Hokland, P
Navara, C
Narla, R
Gaynon, PS
Sather, H
Heerema, N
Citation: Fm. Uckun et al., Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia, LEUK LYMPH, 42(1-2), 2001, pp. 41-56
Citation: Jm. Norgaard et P. Hokland, Biology of multiple drug resistance in acute leukemia. (vol 72, pg 290, 2000), INT J HEMAT, 73(1), 2001, pp. 132-132
Authors:
Norgaard, JM
Langkjer, ST
Palshof, T
Pedersen, B
Hokland, P
Citation: Jm. Norgaard et al., Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia, EUR J HAEMA, 66(3), 2001, pp. 160-167
Authors:
Andersen, MT
Nordentoft, I
Hjalgrim, LL
Christiansen, CL
Jakobsen, VD
Hjalgrim, H
Pallisgaard, N
Madsen, HO
Christiansen, M
Ryder, LP
Clausen, N
Hokland, P
Schmiegelow, K
Melbye, M
Jorgensen, P
Citation: Mt. Andersen et al., Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia, LEUKEMIA, 15(5), 2001, pp. 858-859
Citation: G. Olesen et al., Reduced total number of cobblestone area forming cells and in vitro stromal-cell growth in autografts from acute myeloid leukemia patients, CYTOTHERAPY, 2(3), 2000, pp. 201-209
Authors:
Aggerholm, A
Gronbaek, K
Guldberg, P
Hokland, P
Citation: A. Aggerholm et al., Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders, EUR J HAEMA, 65(2), 2000, pp. 109-113
Authors:
Simonsson, B
Totterman, T
Hokland, P
Lauria, F
Carella, AM
Fernandez, MN
Rozman, C
Ferrant, A
de Witte, T
Zander, AR
Meier, K
Hansson, F
Citation: B. Simonsson et al., Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation, BONE MAR TR, 25(11), 2000, pp. 1121-1127
Authors:
Holm, M
Hoyer, M
Jensen, I
Thomsen, M
Hokland, P
Citation: M. Holm et al., Dynamic cell cycle kinetics in vitro and in vivo in myelodysplastic syndromes with special reference to the influence of hematopoietic growth factors, LEUK RES, 24(12), 2000, pp. 999-1008
Citation: P. Hokland et N. Pallisgaard, Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia, SEM HEMATOL, 37(4), 2000, pp. 358-367
Citation: A. Aggerholm et al., DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?, BLOOD, 95(9), 2000, pp. 2997-2998
Authors:
Pallisgaard, N
Clausen, N
Schroder, H
Hokland, P
Citation: N. Pallisgaard et al., Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript, GENE CHROM, 26(4), 1999, pp. 355-365
Authors:
Hokland, M
Jorgensen, H
Holm, MS
Simonsson, B
Nilsson, B
Bengtsson, M
Hokland, P
Citation: M. Hokland et al., Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation, EUR J HAEMA, 63(4), 1999, pp. 251-258
Authors:
Aggerholm, A
Guldberg, P
Hokland, M
Hokland, P
Citation: A. Aggerholm et al., Extensive intra- and interindividual heterogeneity of p15(INK4B) methylation in acute myeloid leukemia, CANCER RES, 59(2), 1999, pp. 436-441
Citation: M. Holm et al., Dynamic cell cycle kinetics of normal CD34(+) cells and CD38(+/-) subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood, BR J HAEM, 105(4), 1999, pp. 1002-1013
Citation: I. Hansen et al., Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens, EUR J HAEMA, 61(5), 1998, pp. 339-346